The mechanism by which hyperglycaemia causes decreased (Na +, K-)-ATPase activity preventable by aldose reductase inhibitors and by raising plasma myo-inositol in specific tissues can be activated in vitro in normal rabbit aortic wall; it selectively inhibits a component of resting (Na +, K')-ATPase activity maintained by a novel regulatory system through rapid basal phosphatidylinositol turnover (hydrolysis) in a discrete pool, which is replenished by a fraction of phosphatidylinositol synthesis that selectively requires myo-inositol transport. A role for endogenously released adenosine in this regulatory system was examined. Adding adenosine deaminase or 8-phenyltheophylline, an adenosine receptor antagonist, selectively inhibited the component of (Na+, K +)-ATPase activity maintained by the regulatory system; when inhibited with adenosine deaminase this component was restored by 2-chloroadenosine, 5'-N-ethylcarboxamidoadenosine, and 1-oleoyl-2-acetylglycerol, but not by forskolin (which also did not inhibit this component). Adenosine deaminase inhibited the rapid basal turnover of the discrete phosphatidylinositol pool, and 2-chloroadenosine then stimulated its turnover. Raising medium glucose from 5 to 10-30 retool/1 inhibits the regulatory system by making myo-inositol transport at a normal plasma level inadequate to maintain the replenishment of the discrete phosphatidylinositol pool. 2-Chloroadenosine stimulation of the "adenosine-sensitive" component of (Na +, K t)-ATPase activity was inhibited in tissue incubated with 30 mmol/1 glucose and myo-inositol in a normal plasma level, but this effect was demonstrable when the medium myo-inositol was raised seven-fold. Hyperglycaemia-induced decreased (Na ~, K+)-ATPase activity that is preventable by aldose reductase inhibitors and by raising plasma myo-inositol results from the inhibition of a novel adenosine-(Na +, K )-ATPase regulatory system. Key words: (Na +, K')-ATPase, adenosine, glucose, myoinositol, aorta.
Hyperglycaemia decreases (Na +, K+)-ATPase activity and induces functional alterations in peripheral nerve, kidney, and retina by a mechanism whose identifying characteristic is that its effects are preventable by aldose reductase inhibitors and by raising normal plasma myoinositol -seven-fold [1] [2] [3] [4] . This mechanism can be acutely activated and studied in vitro in normal rabbit aortic intima-media (AIM); it was recently found to involve increased polyol pathway activity that impairs myo-inositol transport at a normal plasma level and thereby inhibits a novel (Na +, K + )-ATPase regulatory system present in the tissue [5] . This system controls and maintains a distinct component of resting (Na +, K + )-ATPase activity through rapid basal phosphatidylinositol (PI) turnover in a discrete pool, which reflects PI hydrolysis of some type [6] . The PI pool required for this system's operation is maintained by a distinct fraction of basal de novo PI synthesis that selectively requires myo-inositol transport at a normal micromolar plasma level for its maintenance [5, 6] . In AIM provided with medium rnyo-inositol in a normal plasma level raising medium glucose from a normal (5mmol/1) to a threshold elevated plasma level (10 mmol/1) selectively inhibits the (Na +, K +)-ATPase activity maintained by the regulatory system by inhibiting the fraction of PI synthesis that replenishes the PI pool used as its effector arm; this occurs without a measurable change in total tissue myo-inositol and is prevented by aldose reductase inhibitors and by raising the medium myo-inositol-seven-fold [5] .
Further clarification of the novel (Na +, K § regulatory system is required to understand the implications of its inhibition in the tissues in which hyperglycaemia causes decreased (Na +, K +)-ATPase activity preventable by aldose reductase inhibitors and by raising plasma myo-inositol. Because this system is operative in resting isolated AIM, we examined the possibility that adenosine, a local hormone, is the stimulus for the component of (Na +, K +)-ATPase activity it maintains. Adenosine is released by most tissues in a manner that varies with their activity and energy state and plays an important role in the autoregulation of local metabolism, microcirculatory haemodynamics, and arterial tone [7, 8] . Most adenosine effects are mediated through receptors that inhibit or stimulate adenylate cyclase, but other types of adenosine receptors have been postulated [9] [10] [11] .
Materials and methods
Male, white New Zealand rabbits (2.0-2.5 kg) were fasted overnight, sedated with diazepam (2 mg/kg i. m.), and 90 min later anaesthetized with sodium pentobarbital (30 mg/kg i.v.) and decapitated. The descending thoracic aorta was excised and used to prepare four tubular segments of AIM free of adventitia and retaining an intact endothelium with a normal transmission and scanning electron microscopic appearance by a previously described method [12, 13] . Each AIM segment weighed N30 mg. The aorta was dissected in KrebsHenseleit bicarbonate buffer [14] bubbled with 5% COJ95% 02, pH 7.4 at 37~ that contained normal rabbit plasma levels of glucose (5 mmol/1) and myo-inositol (70 lamol/l), in addition to 9% clinical grade dextran, average mol. wt. 70,000, to provide the oncotic pressure required to preserve AIM's normal ultrastructure and pattern of energy metabolism [12] .
(Na ~ , K +)-ATPase mediated 86Rb+/K+ uptake was compared in paired duplicate AIM samples from the same aorta incubated under conditions that differed in a single parameter using a method detailed in a previous report [5] . Briefly, the individual AIM segments were equilibrated for 30 min in 3 ml of Krebs-Henseleit bicarbonate buffer gassed with 5% COJair that contained 9% dextran, 5 mmol/1 glucose, and a specified concentration ofmyo-inositol, in a 10 ml Erlenmeyer flask in a metabolic shaker set at 88 cycles/min. The AIM segment was then transferred to a fresh medium of the same composition containing an added tracer quantity of [3H]sucrose. Ouabain (0.2 mmol/1) was added to one of the two AIM segments in each paired sample. (This ouabain concentration causes maximal inhibition of (Na +, K +)-ATPase activity in AIM). The agent whose effect on (Na +, K +)-ATPase activity was to be examined was added to one of the paired duplicate AIM samples. The samples were incubated for 30 min, and 20 min prior to the end of the incubation a tracer quantity of [86Rb+]RbC1 was added to each flask. At the end of the incubation the AIM segment was removed and rapidly drained on filter paper, weighed, transferred into 2 ml of Protosol (New England Nuclear, Boston, Mass, USA) in a glass liquid scintillation vial, digested for 16 h, and decolourized with H202. Econofluor-2 (New England Nuclear) was then added and the samples counted in a liquid scintillation spectrometer with an external standard. Samples of incubation medium were counted, and medium K + was also determined. The observed tissue 86Rb + counts were corrected for the ~6Rb + present in retained extracellular fluid in the tissue by means of the [3H]sucrose counts found in the tissue sample and the ratio of the S6Rb + counts/[3H]sucrose counts in the medium. The resulting estimate of intracellular 86Rb+ counts was expressed as btmoI of S6Rb +/K + uptake, g-1.20 min-~ by means of the ratio of the a6Rb + counts in the incubation medium to the medium K + concentration. The difference between the uptakes in the absence and presence of ouabain in the duplicate segments incubated under otherwise identical conditions was used to estimate the (Na + , K')-ATPase-mediated 86Rb+/K + uptake. This method yields linear values in 10 or 20 rain assays in paired samples from the same aorta incubated under the same conditions.
In specific experiments [1,3-14C] glycerol counts in tissue PI were compared in paired samples from the same aorta after a 15 min pulse and after a 30 min chase. Paired AIM samples (each consisting of two segments) were equilibrated for 30 rain in 6 ml of Krebs-Henseleit bicarbonate buffer containing 9% dextran, glucose (5 mmol/1), and a specified myo-inositol concentration. The samples were then incubated in fresh medium of the same composition with added 0.1 mmol/l [1,3-t~C] glycerol, 55 mCi/mmol, for 15 min; one sample was then immediately processed, as described below, and the other sample transferred to fresh medium of the same composition that contained unlabelled glycerol and incubated for an additional 30 rain. Using previously described methods [5] the tissue removed after the pulse or chase were rapidly frozen in liquid N2 that had been previously partially evaporated to its freezing point, weighed, and pulverized in liquid N2 in an all glass homogenizer; the phospholipids were extracted from the frozen tissue powder and the PI isolated by two-dimensional thin layer chromatography and counted.
Ouabain, dextran, 2-chloroadenosine, 5'-N-ethylcarboxamidoadenosine, R-N6-phenylisopropyladenosine, and S-Nqphenylisopropyladenosine were obtained from Sigma Chemical Co., (St. Louis, Mo., USA). Adenosine deaminase was purchased from Boehringer Mannheim Biochemicals, (Indianapolis, Ind., USA) 
Statistical analysis
The mean A_+ SEM between the paired samples in each group of paired experiments was analysed for significance by a paired t-test analysis.
Results
The (Na § K § activity operative in resting AIM incubated in Krebs-Henseleit bicarbonate buffer containing normal plasma levels of Na +, K +, glucose (5 retool/l), and myo-inositol (70 ~tmol/1), and 9% dextran is comprised of two distinct components; if the medium myoinositol is removed (or if a competitive inhibitor of myoinositol transport is added) the component maintained by a novel regulatory system is selectively inhibited within 30 min (the equilibration period) leaving another stable component of (Na § K+)-ATPase activity that does not require medium rnyo-inositol for its maintenance [5, 6] . (A threshold level of medium myo-inositol (50 gmol/1) is required to maintain the component controlled by the regulatory system, whose magnitude is unaffected by further increases in medium myo-inositol in tissue incubated with 5 retool/1 glucose [5, 6] .) We examined the effects on these two components of resting (Na +, K § activity of adding adenosine deaminase (ADA) (1 U/ml) to degrade endogenously released adenosine. ADA inhibited a major fraction of the activity operative in AIM provided with medium myo-inositol in a normal plasma level, but had no effect on the component that remains operative in myo-inositol-free medium (Table1). 8-Phenyltheophylline, an adenosine receptor antagonist with a high affinity for both A1 and A2 receptors [9, 11] , also selectively inhibited the component that requires medium myo-inositol and is maintained by the regulatory system (Table 1) . When this component was inhibited with ADA it could be restored by adding 2-chloroadenosine (10 ~tmol/1), a water soluble adenosine analogue that is not a substrate for ADA [9] (Table 1) . This 2-chloroadenosine stimulation of Table 1 . Effects of adenosine deaminase (ADA) (1 U/ml), 8-phenyltheophylline (10 bLmol/1) and 2-chloroadenosine on (Na +, K +)-ATPase activity in rabbit aortic intima-media (AIM) in medium containing or lacking myo-inositol 
inositol ( -) ).
The additions noted were added to the incubation medium. Ouabain (0.2 mmol/1) was added to one of the two AIM segments in each paired sample during the incubation. 8-Phenyltheophylline was added in dimethyl sulfoxide (final medium concentration 0.1% ) which was added to the paired controls. (Na ~, K" )-ATPase-mediated 86Rb § + uptake was assessed during the final 20 min of the incubation. Values are means and mean 2x _+ SEM between the paired samples, p was determined by a paired t-test analysis The experiments were performed as described in the legend for Table 1 . Forskolin (50 gmol/1) was added in an ethanol solution, final medium ethanol concentration 0.1%. The conditions with regard to the presence (+) or absence (-) of medium myo-inositol (70 gmol/1) and of medium adenosine deaminase (1 U/ml) were the same for both paired samples. ADA = adenosine deaminase a distinct component of (Na +, K+)-ATPase activity was not demonstrable when the medium myo-inositol was omitted (Table 1 ). These observations demonstrate that endogenously released adenosine is the stimulus for the component of (Na +, K § activity maintained by the regulatory system.
The requirement for medium myo-inositol for the adenosine effect on (Na +, K +)-ATPase activity in AIM distinguishes this effect from all previously reported adenosine effects in isolated tissues and cultured cells, most of which are attributable to receptors that inhibit (A1) or stimulate (A2) adenylate cyclase [9] [10] [11] . When the adenosine-stimulated component of (Na +, K +)-ATPase activity was inhibited with ADA or by using myo-inositolfree medium it was not restored by forskolin, a direct stimulator of adenylate cyclase [15] , in concentrations as high as 50 btmol/1 ( Table 2) . Forskolin also had no effect on (Na +, K +)-ATPase activity when added to AIM in which the adenosine-stimulated component was operative (Table 2 ), but would have been expected to cause a decrease if the adenosine effect were mediated through a receptor that inhibits adenylate cyclase [9] . These observations suggest that the adenosine effect is not mediated through a receptor 'whose transduction mechanism is an inhibition or stimulation of adenylate cyclase. When the adenosine-stimulated component of (Na +, K +)-ATPase activity was inhibited with ADA it was restored by 10 btmol/1 2-chloroadenosine (Table 1 ) and by 0.2 btmol/1 5'-N-ethylcarboxamidoadenosine (Table 3) , but in concentrations as high as 100 btmol/1 neither R-N6-phenylisopropyladenosine or S-N6-phenylisopropyladenosine had an effect (Table 3 ). The apparent relative potencies of these adenosine analogues suggest that the adenosine effect is probably mediated through a variant type of A2 receptor [9, 11] .
The relationship between endogenously released adenosine and the rapid basal turnover of the discrete PI pool was examined in studies that had the following basis. In AIM incubated with normal plasma levels of glucose and myo-inositol basal de novo PI synthesis is comprised of two distinct fractions, one of which is selectively inhibited if the medium myo-inositol is removed to inhibit myo-inositol transport [6] . The fraction that remains operative in myo-inositol-free medium forms labelled PI during a 15 min pulse with [1,3-~4C] glycerol that remains stable during a 30 min chase [6] , as illustrated by the pulsechase study in myo-inositol-free medium in Table 4 . The fraction of basal de novo PI synthesis that requires medium rnyo-inositol in a normal plasma level replenishes the discrete PI pool with a rapid basal turnover; this frac- The experiments were performed as described in legend for Table 1 . All incubation media contained myo-inositol (70 gmol/1) and 0.1% dimethyl sulfoxide, the solvent for the adenosine analogues tested-ADA = adenosine deaminase myo-inositol; in specific experiments the myo-inositol was omitted (Medium myo-inositol ( -) ). In specific experiments additions to the medium were made during the chase, adenosine deaminase (ADA) (1 U/mI) alone or in combination with 2-chloroadenosine (10 gmol/1). Values are means and mean 2x + SEM between the paired samples, p was determined by a paired t-test analysis tion forms an additional component of glycerol-labelled PI during a 15 min chase that disappears during a 30 rain chase [6] . Thus, as illustrated in Table 4 , when paired AIM samples are provided with 70 gmol/1 medium myo-inositol during a 15 min pulse with 0.1 mmol/l [1,3-14C]glycerol and one sample is then subjected to a 30 min chase, there is a significant decrease in the counts in PI during the chase that reflects the rapid basal turnover of the labelled PI in the discrete PI pool. This decrease in labelled PI was inhibited when ADA (1 U/ml) was added during the chase (Table 4) , and under these conditions adding 2-chloroadenosine (10 gmol/1) stimulated a loss of PI (Table 4 ). These observations support the conclusion that endogenously released adenosine is the stimulus for the rapid basal PI turnover in a discrete pool that is the effector arm of the (Na +, K § regulatory system. The basal turnover of the discrete PI pool is not attributable to its use for phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-biphosphate formation and reflects PI hydrolysis of some type [6] . When the adenosine-stimulated component of (Na +, K § )-ATPase activity was selectively inhibited with ADA or by omitting medium myo-inositol it was restored by 1-oleoyl-2-acetylglycerol (100 Bmol/l), a synthetic sn-l,2-diacylglycerol that can activate some protein kinase(s) C when added to intact cells [16] (Table 5 ). In contrast, 1-oleoyl-2-acetylglycerol did not stimulate (Na +, K § activity in AIM in which the adenosine-stimulated component was operative, but rather caused a small decrease (Table 5 ). These observations suggest that the adenosine stimulation of a distinct component of (Na-, K § activity is mediated through diacylglycerol release and that adenosine probably stimulates a phospholipase C hydrolysis of PI in the discrete PI pool.
In AIM provided with medium myo-inositol in a normal plasma level raising the medium glucose to 30 mmol/1 selectively inhibits the component of (Na + , K" )-ATPase activity controlled by the regulatory system by inhibiting the fraction of PI synthesis that replenishes the discrete PI pool, and these effects are prevented if the medium myoinositol is raised from 70 to 500 gmol/1 [5] . We examined the ability of 2-chloroadenosine (10 gmol/l) to stimulate the "adenosine-sensitive" component of (Na +, K +)-ATPase activity under these two conditions, with ADA added to degrade endogenously released adenosine. 2-Chloroadenosine did not stimulate (Na +, K +)-ATPase activity in AIM incubated with 30 mmol/1 glucose and myoinositol in a normal plasma level, but did cause a stimulation in tissue incubated with 30 mmol/1 glucose when the medium myo-inositol was raised -seven-fold (Table 6 ). This supports the inference that exposing AIM to medium glucose in an elevated plasma level decreases Table 5 , Effects of 1-oleoyl-2-acetylglycerol on (Na + , K-)-ATPase activity in rabbit aortic intima-media The experiments were performed as described in legend for Table 1 . The conditions with regard to the presence ( + ) or absence ( -) of medium myo-inositol (70 btmol/1) and of medium adenosine deaminase (ADA) (1 U/ml) were the same for both paired samples. The 1-oleoyl-2-acetylglycerol (100 gmol/1) was added in a dimethyl sulfoxide suspension sonicated to prepare micelles [17] ; the same final medium dimethyt sulfoxide concentration (0.3 %) was added to the paired controls Experiments performed as described in legend for Table 1 , but with the medium glucose raised to 30 mmol/1 during the equilibration (30 rain) and incubation (30 rain). The adenosine deaminase (ADA) (1 U/ml) and 2-chloroadenosine (10 ~tmol/1) were added to the incubation medium (Na +, K § )-ATPase activity by inhibiting a specific adenosine effect.
Discussion
When the mechanism by which hyperglycaemia causes decreased (Na +, K +)-ATPase activity in specific tissues that is preventable by aldose reductase inhibitors and by raising plasma myo-inositolis activated in vitro in AIM it inhibits a novel (Na +, K +)-ATPase regulatory system, whose effector arm is rapid basal PI turnover in a discrete pool [5, 6] .
The studies reported above demonstrate that this is a previously unrecognized adenosine (Na +, K + )-ATPase regulatory system, by which endogenously released adenosine regulates (stimulates) and normally maintains a distinct component of (Na +, K +)-ATPase activity in resting AIM. This adenosine effect is mediated through a novel type of adenosine receptor, apparently a variant type of A2 receptor, that stimulates rapid basal PI turnover in a discrete pool. The rapid b as al turnover of this PI pool is not attributable to its use for polyphosphoinositide formation and reflects PI hydrolysis of some type [6] . When the adenosinestimulated component is selectively inhibited by adding adenosine deaminase or by using myo-inositol-free medium to inhibit the replenishment of the discrete PI pool, it can be restored by adding a synthetic sn-l,2-diacylglycerol, 1-oleoyl-2-acetylglycerol, which can activate some protein kinase(s) C in intact cells [16] ; whereas in tissue in which the adenosine-stimulated component is operative 1-oleoyl-2-acetylglycerol does not stimulate (Na +, K + )-ATPase activity. These observations suggest that adenosine probably stimulates a phospholipase C hydrolysis of PI in the discrete PI pool that acts by a release of diacylglycerol at specific membrane sites to stimulate the distinct component of (Na +, K + )-ATPase activity. Whether adenosine selectively stimulates the activity of a specific (Na +, K *)-ATPase isoform in one or both major cell types in AIM remains to be clarified. A striking feature of this regulatory system is its requirement for rnyo-inositol transport at a normal micromolar plasma level to maintain its operation [5, 6] . The PI pool used by this system is replenished by a distinct fraction of de novo PI synthesis that behaves as though it were localized in a specific cell type or subcellular site (PI synthesis occurs in both plasma membrane and endoplasmic reticulum [17] ), where it requires a small myo-inositol pool that is peculiarly dependent on rnyo-inositol transport for its maintenance [5, 6] . Myo-inositol transport is not one of the major mechanisms by which most tissues maintain high rnyo-inositol contents comprised of heterogeneous pools [18] . AIM does not require medium myoinositol during incubations with glucose in a normal or elevated plasma level to prevent any measurable decrease in its high normal rnyo-inositol content (5.80+_ 0.43 mmol/kg), to maintain another major fraction of de novo PI synthesis, or to maintain its normal low basal incorporations of labelled glycerol and arachidonic acid into polyphosphoinositides [5, 6, 19] . The biological rationale for having the adenosine effect on (Na +, K +)-ATPase activity mediated through a PI pool that is critically dependent on rnyo-inositol transport for its maintenance remains to be clarified. However, this explains why the effect of endogenously released adenosine (and of 2-chloroadenosine) on (Na + , K +)-ATPase activity is subject to quite rapid inhibition when an elevated extracellular glucose level induces increased polpol pathway activity that makes rnyo-inositol transport at a normal extracellular level inadequate to maintain the replenishment of the discrete PI pool [5] . It is of note that in normal resting periph-D. A. Simmons and A. I. Winegrad: Adenosine-(Na', K T)_ATPase regulatory system eral nerve endoneurium inhibiting myo-inositol transport by omitting it from the medium also causes rapid and selective inhibitions of distinct fractions of normal PI synthesis and (Na +, K+)-ATPase activity [20] , and that the decreased (Na +, K~)-ATPase activity in endoneurium from diabetic rabbits is acutely corrected by a synthetic diacylglycerol that can activate some protein kinase(s) C [21] .
The general pattern of adenosine's diverse effects is believed to be designed to modulate local tissue metabolism and circulation and the effects of external stimuli (e. g. specific hormones and neurotransmitters) in accordance with information about local tissue activity and energy state provided by adenosine release, and to thereby help to maintain normal energy balance [7] . The adenosine-(Na § K+)-ATPase regulatory system identified in AIM has an obvious potential for use in mediating such acute autoregulatory effects. An acute increase in electrogenic (Na +, K+)-ATPase activity that raises the membrane potential is one of the mechanisms by which factors released by blood vessels normally modulate vascular smooth muscle tone and its contractile response to neurotransmitters and hormones [22] , and adenosine's previously unknown effect on aortic (Na +, K +)-ATPase activity may well reflect one of the mechanisms by which it plays its role in the autoregulation of arterial tone and of microcirculatory haemodynamics [8] . Thus a hyperglycaemia-induced inhibition of the adenosine-(Na +, K+) -ATPase regulatory system in a tissue in which it normally operates has the potential of causing effects that are not restricted to the diverse effects that can be evoked by a persistent abnormally low level of (Na +, K + )-ATPase activity; for it might also cause effects that result from inhibiting one of the adenosine effects normally utilized in acute vascular autoregulation. This is a potential explanation for the relationship between the mechanism by which hyperglycaemia causes decreased (Na +, K +)-ATPase activity preventable by aldose reductase inhibitors and by raising plasma myo-inositol and the development in some of the affected tissues of functional alterations that reflect a derangement in vascular regulation (e.g. glomerular hyperfiltration, increased retinal blood flow) [3, 4] . This speculation is supported by the recent observation that adenosine's normal effect on glomerular filtration rate (a decrease) is inhibited in diabetic rats and is restored when they are treated with an aldose reductase inhibitor [23] .
The distinction between the basal PI turnover involved in the adenosine-(Na § K*)-ATPase regulatory system and classic agonist stimulated phosphoinositide turnover requires emphasis. Stimulation of a resting tissue by a hormone or neurotransmitter whose receptor's transduction mechanism is activation of phospholipase C hydrolysis of phosphatidylinositol 4,5-bisphosphase and a release of Dmyo-inositol t,4,5-P3 (which raises cytosolic Ca 2+) and of diacylglycerol characteristically evokes acute sequential increases in the turnovers of discrete pools of phosphatidylinositol 4,5-bisphosphate and of PI; the increased PI turnover reflects, in part, a secondary, non-receptor controlled increase in PI hydrolysis in specific PI pools [25, 26] . Phospholipase C hydrolysis of phosphatidylinositol 4,5-bisphosphate has been thought to be the only receptor transduction mechanism that involes a phosphoinositide [25, 26] . It has long been known that in a number of resting tissues a small PI pool exhibits persistent rapid basal turnover [27, 28] , but its significance has been unknown. Our observations demonstrate that in resting AIM rapid basal PI turnover in a discrete pool reflects the transduction mechanism of a novel adenosine receptor. It is of note that in contrast to the requirement for medium rnyo-inositol for the adenosine effect on (Na +, K~)-ATPase activity, the effects of agonists that stimulate phosphatidylinositol 4,5-bisphosphate hydrolysis and a secondary increase in PI turnover in specific PI pools in aorta and cultured aortic cell types (e. g. angiotensin II, norepinephrine) have been routinely demonstrated in myo-inositol-fl'ee medium [29] [30] [31] , and the maintenance of the phosphatidylinositol 4,5-bisphosphate and PI pools required for their effects does not appear to be critically dependent on myo-inositol transport. Aortae from diabetic rats exhibit an increased contractile response to angiotensin II and norepinephrine [32, 33] ; whether this is a secondary consequence of inhibition of the adenosine-(Na +, K +)-ATPase regulatory system remains to be clarified, but this is a possible explanation.
